Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hello Alpha vs Omada Health

Hello Alpha
Graded #354

Higher grade

vs+3.299999999999997
Omada Health
Graded #435

Lower grade

The verdict

Hello Alpha takes it — 58.9/100 to 55.6/100.

Hello Alpha grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Hello Alpha (formerly Alpha Medical) is a US telehealth platform offering a full weight-loss lineup: branded GLP-1s including Wegovy, Ozempic, Rybelsus, Zepbound and Mounjaro, plus the oral GLP-1 Foundayo…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationHello Alpha +24
64
40
Clinical oversightEven
77
77
Labs & monitoringOmada Health +7
54
61
FulfillmentHello Alpha +5
67
62
Contract termsOmada Health +14
41
55
Hello Alpha · left barOmada Health · right bar

The numbers

MetricHello AlphaOmada Health
WeighScore58.9/10055.6/100
GradeCC
Scorecard rank#354#435
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
Hello Alpha

Graded #354 · C

Strengths

  • Full branded GLP-1 lineup: Wegovy, Ozempic, Rybelsus, Zepbound, Mounjaro
  • Offers the oral GLP-1 Foundayo plus oral weight-loss medications
  • Works with insurance
  • Ongoing clinician care via online membership

Where it loses points

  • Cash pricing is not published on the public site
  • Full state list is not enumerated
  • Insurance coverage of the medication still depends on your plan
Omada Health

Graded #435 · C

Strengths

  • Added GLP-1 prescribing and medication management in late 2025
  • Clinicians trained in obesity care, available in all 50 states
  • Behavioral support wrapped before, during and after treatment
  • GLP-1 Flex Care adds a cash-pay medication pathway in 2026
  • Publicly traded, evidence-based virtual care platform

Where it loses points

  • Core program distributed via employers and health plans, limited cash-pay
  • GLP-1 prescribing is a recent addition still scaling
  • GLP-1 Flex Care only rolling out to employers later in 2026
  • No transparent published price for the core member program

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard